Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 07, 2024
Displaying entries 38101 - 38150 of 39437 in total
PDB ID UniProt ID Title ▼ Descriptor
8AQW P10104 BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQW P0DTC2 BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQS P10104 BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local)
8AQS P0DTC2 BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local)
8AQS Q9BYF1 BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local)
8XUU P0DTC2 BA.2.86-T356K Spike Trimer in complex with heparan sulfate (Local refinement)
8X4Z P0DTC2 BA.2.86 Spike Trimer with ins483V mutation (3 RBD down)
8X50 P0DTC2 BA.2.86 Spike Trimer with ins483V mutation (1 RBD up)
8X55 P0DTC2 BA.2.86 Spike Trimer with T356K mutation (3 RBD down)
8X56 P0DTC2 BA.2.86 Spike Trimer with T356K mutation (1 RBD up)
8XUR P0DTC2 BA.2.86 Spike Trimer in complex with heparan sulfate
8WHZ Q9BYF1 BA.2.86 RBD in complex with hACE2 (local refinement)
8WHZ P0DTC2 BA.2.86 RBD in complex with hACE2 (local refinement)
8AQV P01865 BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQV Q8R0I0 BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQV P10104 BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQV P0DTC2 BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8CIM P10104 BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN
8CIM P0DTC2 BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN
8CIM 8CIM BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN
8WGV P0DTC2 BA.2(S375) Spike (S6P)/hACE2 complex
8WGV Q9BYF1 BA.2(S375) Spike (S6P)/hACE2 complex
8AQU P01865 BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQU Q8R0I0 BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQU P10104 BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQU P0DTC2 BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8OWW P0DTC2 B5-5 nanobody bound to SARS-CoV-2 spike RBD (Wuhan)
8OWW 8OWW B5-5 nanobody bound to SARS-CoV-2 spike RBD (Wuhan)
6OKP B3UEZ6 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP B3UES2 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP S6B291 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP 6OKP B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP S6B291 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP 6OKP B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP Q8N5F4 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP Q8N5F4 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP P01834 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP P01834 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6EDU B3UEZ6 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6EDU B3UES2 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6EDU P01730 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6EDU 6EDU B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
3CKB Q8A1G2 B. thetaiotaomicron SusD with maltotriose
3CK9 Q8A1G2 B. thetaiotaomicron SusD with maltoheptaose
3CK8 Q8A1G2 B. thetaiotaomicron SusD with beta-cyclodextrin
3CK7 Q8A1G2 B. thetaiotaomicron SusD with alpha-cyclodextrin
7R55 F2UID9 B-trefoil lectin from Salpingoeca rosetta in complex with Gb3
7QE4 F2UID9 B-trefoil lectin from Salpingoeca rosetta in complex with GalNAc
2PYH Q44493 Azotobacter vinelandii Mannuronan C-5 epimerase AlgE4 A-module complexed with mannuronan trisaccharide
5ZCQ P00396 Azide-bound cytochrome c oxidase structure determined using the crystals exposed to 10 mM azide solution for 2 days
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024